Last reviewed · How we verify
NCT06632132
Antimicrobial Resistance Training for Hemodialysis Nurses
NA trial testing Antimicrobial resistance Training in Hemodialysis Units in Antimicrobial Resistance in Hemodialysis in 64 participants. Completed in 2 July 2024.
1 July 2024
Quick facts
| Lead sponsor | Jordan University of Science and Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 64 |
| Start date | 1 June 2024 |
| Primary completion | 1 July 2024 |
| Estimated completion | 2 July 2024 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Antimicrobial resistance Training in Hemodialysis Units
Conditions studied
- Antimicrobial Resistance in Hemodialysis — all drugs for Antimicrobial Resistance in Hemodialysis →
Sponsor
Jordan University of Science and Technology
Who can join
18 and older, any sex, with Antimicrobial Resistance in Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: To evaluate the impact of an m-health training program on nurses' knowledge, attitudes, and practices concerning antimicrobial resistance (AMR) within hemodialysis units. Design: This study utilized a controlled experimental design with cluster random assignment, adhering to the Consolidated Standards of Reporting Trials (CONSORT) guidelines. Method: A convenience sample of 64 nurses was cluster-randomized into either an experimental group (n = 32) or a control group (n = 32). The experimental group received AMR education via WhatsApp using Chabot software, while the control group received the same content through leaflets. The nurses' knowledge, attitudes, and practices regarding AMR were assessed with self-developed instruments at three time points: baseline (Time 1), immediately after the intervention (Time 2), and one month later (Time 3).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Boosting knowledge, attitudes, and practices: An experimental controlled study evaluating the effectiveness of m-health training on antimicrobial resistance for hemodialysis nurses.
Alhawatmeh H, Aljarrah M, Hweidi IM, Al-Nsair N, et al · · 2025 · cited 2× · PMID 39943979 · DOI 10.1177/20503121251318153
Verify or expand the search:
- PubMed search for NCT06632132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Jordan University of Science and Technology trials
Trials by the same sponsor.
- NCT07504614 — Pre-etched Bioactive Versus Resin- Based Fissure Sealant for Permanent Molars Affected With Molar Incisor Hypomineraliza · NA · enrolling by invitation
- NCT07522216 — Effect of Clear Aligner Wear Protocol on External Root Resorption · NA · active not recruiting
- NCT07167654 — Smartphone Application to Support Mothers at Risk of Postpartum Depression · NA · active not recruiting
- NCT07318298 — Effect of Injectable Hyaluronic Acid (HYADENT BG (HA)) on Bone Healing in Extraction Sockets · NA · recruiting
- NCT06635278 — Mindfulness Meditation: Alleviating Symptoms and Inflammation in Nurses · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06632132 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jordan University of Science and Technology
- Last refreshed: 8 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06632132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing